de Azevedo, R. A., Shoshan, E., Whang, S., Markel, G., Jaiswal, A. R., Liu, A., . . . Bar-Eli, M. (2020). MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma. Oncoimmunology.
Chicago-stil citatde Azevedo, Ricardo A., Einav Shoshan, Shanzhi Whang, Gal Markel, Ashvin R. Jaiswal, Arthur Liu, Michael A. Curran, Luiz R. Travassos, och Menashe Bar-Eli. "MIF Inhibition As a Strategy for Overcoming Resistance to Immune Checkpoint Blockade Therapy in Melanoma." Oncoimmunology 2020.
MLA-referensde Azevedo, Ricardo A., et al. "MIF Inhibition As a Strategy for Overcoming Resistance to Immune Checkpoint Blockade Therapy in Melanoma." Oncoimmunology 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.